News
Precision medicine is a fast-growing field whereby medical treatments are tailored to individual patients – taking factors like genetics and lifestyle into account. A key part of this process is ...
Decoding human tissue The researchers believe these rules may apply not just to the colon, but to many different tissues throughout the body-skin, liver, brain and beyond.
3D-printed tumor models mimic human tissue to improve surgical imaging research by Ashlyn Grotegut, Texas Tech University edited by Sadie Harley, reviewed by Andrew Zinin Editors' notes ...
Chart Industries Inc. (NYSE:GTLS) is one of the 10 most undervalued industrial stocks to buy according to analysts.
For example, in engineering artificial tissue, scientists might optimize intercellular flow within the tissue to improve its function or resilience.
U.S.-based equipment manufacturer Chart Industries and flow control systems maker Flowserve Corp agreed to merge in an all-stock deal, valuing the combined company at about $19 billion.
Industrial companies Chart Industries Inc. and Flowserve Corp. agreed to merge in a deal valuing the combined company at about $19 billion.
This communication may be deemed to be solicitation material in respect of the proposed merger transaction between Chart Industries, Inc. (“Chart”) and Flowserve Corporation (“Flowserve”).
Vivodyne, a Penn spinout that creates human tissue to replace animal testing in drug development, has raised $40 million in a second round of venture capital investment. “Nineteen out of 20 drugs that ...
95% of clinical trials fail because animal testing is no substitute for human biology - Vivodyne’s robotics platform grows thousands of human tissues daily, directly tackling the biological gap ...
A startup seeking to replace animal testing with a sophisticated high-tech platform has raised $40 million to develop lab-grown organs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results